- Home
- EXEL vs ODC Comparison
EXEL vs ODC Comparison
Compare EXEL & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ODC
- Stock Information
- Founded
- EXEL 1994
- ODC 1941
- Country
- EXEL United States
- ODC United States
- Employees
- EXEL N/A
- ODC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ODC Miscellaneous manufacturing industries
- Sector
- EXEL Health Care
- ODC Consumer Discretionary
- Exchange
- EXEL Nasdaq
- ODC Nasdaq
- Market Cap
- EXEL 9.8B
- ODC 316.2M
- IPO Year
- EXEL 2000
- ODC N/A
- Fundamental
- Price
- EXEL $37.43
- ODC $41.97
- Analyst Decision
- EXEL Buy
- ODC
- Analyst Count
- EXEL 18
- ODC 0
- Target Price
- EXEL $37.59
- ODC N/A
- AVG Volume (30 Days)
- EXEL 2.4M
- ODC 34.4K
- Earning Date
- EXEL 05-02-2025
- ODC 06-05-2025
- Dividend Yield
- EXEL N/A
- ODC 1.48%
- EPS Growth
- EXEL 170.77
- ODC 18.90
- EPS
- EXEL 1.76
- ODC 3.13
- Revenue
- EXEL $2,168,701,000.00
- ODC $465,340,000.00
- Revenue This Year
- EXEL $5.82
- ODC N/A
- Revenue Next Year
- EXEL $10.81
- ODC N/A
- P/E Ratio
- EXEL $21.27
- ODC $13.42
- Revenue Growth
- EXEL 18.50
- ODC 8.24
- 52 Week Low
- EXEL $20.14
- ODC $29.48
- 52 Week High
- EXEL $40.02
- ODC $49.72
- Technical
- Relative Strength Index (RSI)
- EXEL 57.87
- ODC 39.19
- Support Level
- EXEL $35.34
- ODC $41.55
- Resistance Level
- EXEL $37.67
- ODC $42.93
- Average True Range (ATR)
- EXEL 1.32
- ODC 1.42
- MACD
- EXEL 0.22
- ODC -0.15
- Stochastic Oscillator
- EXEL 95.46
- ODC 16.39
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.